Skip to main content
. 2016 Sep 13;7(42):69087–69096. doi: 10.18632/oncotarget.12011

Table 2. Newcastle-Ottawa Quality Assessment Scale of included studies.

Study Selection Comparability Outcome Score
Representativeness of Exposed Cohort1 Selection of Nonexposed Group2 Ascertainment of Exposure3 Outcome of Interest4 Comparability of Cohorts5 Assessment of Outcome6 Length of Follow-up7 Adequacy of Follow-up8
Chen[14] 1 1 1 1 1 1 1 1 8
Zhang[15] 1 1 0 1 2 1 1 0 7
Yang [16] 1 0 1 1 1 1 1 1 7
Zheng [17] 1 1 1 1 2 1 1 1 9
Qi [18] 1 1 1 1 2 1 1 1 9
Liu [19] 1 1 1 1 2 1 0 1 8
Wang[20] 1 1 1 1 2 1 1 1 9
Yan[21] 1 1 1 1 2 1 0 0 7
Feng[22] 1 1 1 1 2 1 1 1 9
Ouyang[23] 1 1 1 1 2 1 0 1 8
Rong [24] 1 1 1 1 2 1 0 1 8
Ma[25] 1 1 1 1 2 1 0 1 8

Score was achieved for each item if.

1.

The exposed cohort truly or somewhat represented the average in the community.

2.

The non-exposed cohort was drawn from the same community as the exposed cohort.

3.

Ascertainment of exposure was secure record or structured interview.

4.

Outcome of interest was not present at start of study.

5.

Study controls for the most important factor.

6.

Assessment of outcome was from independent blind assessment or record linkage.

7.

Follow-up was long enough for outcomes to occur.

8.

No subject lost to follow-up or subjects lost to follow-up unlikely to introduce bias or description provided of those lost.